Brief: Helix Biopharma appoints Zbigniew Markowski as CEO
12/01/2016 13:01
Jan 12 (Reuters) - Helix Biopharma Corp HBP.TO : * Announces appointment of permanent new CEO and changes at board level * Says has appointed Zbigniew Markowski as chief executive officer * Says appointed Zbigniew Markowski as CEO, replacing Gary Littlejohn who was serving as interim CEO * Yvon Bastien announced his resignation as chairman of the board and will be replaced by Sven Rohmann * Source text for Eikon ID:nMKW5gFKya * Further company coverage HBP.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020